logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Kosenda Pharmaceutical (02273.HK) spent HKD 2.6396 million on September 16 to repurchase 81,700 shares.

date
16/09/2025
JRJ Financial News App, Gu Sheng Tang (02273.HK) announced that on September 16, 2025, the company repurchased 81,700 shares at a cost of 2.6396 million Hong Kong dollars, with a repurchase price of 32.12-32.40 Hong Kong dollars per share.
Latest
2 m ago
Movement in US Dollar Bonds | Country Garden COGARD 2.7 07/12/26 fell by 1.248% to 10.379
2 m ago
Movement in US Dollar Bonds | Longfor Group LOGPH 4.85 12/14/26 saw a price increase of 1.793% to 8.219.
2 m ago
Tenyuan Cobalt (301219.SZ) 118 million restricted shares will be listed and tradable on September 18th.
3 m ago
Due to the existence of problems such as improper management of asset management business, Dongfang Huijin Futures has been ordered by regulators to make corrections.
3 m ago
Australia and New Zealand Bank: Wind power generation increases significantly, European natural gas prices fall.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.